CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

CRISPR Therapeutics (CRSP) Prices 4.21M Share Common Offering at $47.50/ShSeptember 21, 2018 5:44 AM CRISPR Therapeutics Announces Proposed Public Offering of Common SharesSeptember 19, 2018 4:08 PM CRISPR Therapeutics (CRSP) files automatic mixed securities shelf of an unspeciifed amountSeptember 19, 2018 4:06 PM